TGA Approval

TAKHZYRO lanadelumab (rch) 300mg/2mL solution for injection vial (302300)

ARTG ID

302300

ARTG Name

TAKHZYRO lanadelumab (rch) 300mg/2mL solution for injection vial

Sponsor

Takeda Pharmaceuticals Australia Pty Ltd

ARTG Date

January 30, 2019

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

TAKEDA PHARMACEUTICALS AUSTRALIA PTY. LTD.

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2019-PI-01119-1

Ingredient Name

lanadelumab

Empowering clinical research with data-driven insights and AI-powered tools.